The global hospital services market is projected to expand from USD 9.29 trillion in 2022 to approximately USD 21.27 trillion by 2032, reflecting a compound annual growth rate (CAGR) of 9.15% over the forecast period.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5005
Hospital services, which encompass all the care provided to both inpatient and outpatient patients, have seen significant growth in recent years. This trend is expected to continue, driven by the increasing prevalence of various diseases and illnesses, along with greater awareness among patients seeking treatment.
The rise in chronic conditions such as cardiovascular diseases, cancer, and other long-term illnesses has been a major factor in the expansion of the global hospital services market. Despite this, the COVID-19 pandemic caused a disruption in regular hospital services between 2019 and 2020. During this time, hospitals primarily focused on treating COVID-19 patients and providing emergency care, causing non-emergency services like routine check-ups to be delayed. However, as the pandemic was brought under control, non-emergency services gradually resumed, though at a slower pace.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/hospital-services-market
Access exclusive insight now @ https://www.towardshealthcare.com/price/5005
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
Kedrion Biopharma has announced that its human coagulation factor X concentrate, COAGADEX®, has been granted orphan drug designation by the… Read More
enecard PBF, a pioneer in pharmacy benefit facilitation, has announced a strategic partnership with DecisionRX, Inc., a leader in medication… Read More
In a high-stakes biotech industry where drug development can span over a decade, four small but determined biotech companies are… Read More
cell-free DNA and precision medicine, has officially announced the launch of the TEODOR trial (ABCSG 61), a groundbreaking phase 2,… Read More
The global interventional radiology market is witnessing rapid expansion, driven by advancements in minimally invasive procedures, rising demand for diagnostic… Read More
The global physical therapy market is valued at USD 28.06 billion in 2024, growing to USD 29.18 billion in 2025… Read More